Simplex Trading, LLC Sc Pharmaceuticals Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

A detailed history of Simplex Trading, LLC transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 14,618 shares of SCPH stock, worth $49,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,618

Holding current value

$49,116

% of portfolio

0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$4.12 - $5.51 $60,226 - $80,545	14,618 New	14,618 $66,000
Q4 2023 Feb 02, 2024	BUY	$4.7 - $6.63 $15,279 - $21,554	3,251 New	3,251 $20,000
Q2 2023 Aug 04, 2023	BUY	$8.94 - $11.74 $143,361 - $188,262	16,036 Added 214.04%	23,528 $239,000
Q1 2023 Apr 27, 2023	SELL	$5.59 - $9.47 $108,205 - $183,310	-19,357 Reduced 72.1%	7,492 $67,000
Q4 2022 Feb 02, 2023	BUY	$4.02 - $7.53 $22,632 - $42,393	5,630 Added 26.53%	26,849 $192,000
Q3 2022 Nov 04, 2022	SELL	$4.48 - $6.52 $173,358 - $252,297	-38,696 Reduced 64.58%	21,219 $138,000
Q2 2022 Aug 03, 2022	BUY	$4.3 - $6.48 $158,063 - $238,198	36,759 Added 158.75%	59,915 $288,000
Q1 2022 May 02, 2022	BUY	$3.9 - $6.11 $88,206 - $138,189	22,617 Added 4196.1%	23,156 $131,000
Q4 2021 Feb 23, 2022	BUY	$3.88 - $6.9 $2,091 - $3,719	539 New	539 $2,000

Others Institutions Holding SCPH

# of Institutions

Shares Held

37M

Call Options Held

110K

Put Options Held

12.1K

Orbimed Advisors LLC San Diego, CA

6.06M
Shares

$20.4 Million
0.65% of portfolio
Rubric Capital Management LP New York, NY

4.78M
Shares

$16 Million
0.61% of portfolio
Aigh Capital Management LLC Baltimore, MD

4.12M
Shares

$13.9 Million
7.6% of portfolio
King Luther Capital Management Corp Fort Worth, TX

2.23M
Shares

$7.48 Million
0.04% of portfolio
Suvretta Capital Management, LLC New York, NY

2.05M
Shares

$6.88 Million
0.37% of portfolio

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $92.1M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account